SCHEMBL1503586

SCHEMBL1503586

C[C@](CNC(=O)c1ccc(OCc2ccnc(-c3ccccc3C(F)(F)F)c2)cc1)(C(=O)O)N1CCOCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 4/20 0.51
ALDH1A1 P00352 3/20 0.44
RAF1 P04049 2/20 0.40
BRAF P15056 2/20 0.40
POLB P06746 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
MAPK14 Q16539 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
HDAC1 Q13547 2/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM1A O60341 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10475832 0.83 ADAM17 (0.68) ADAM17RAF1BRAFMEN1KMT2A
SCHEMBL10475836 0.83 ADAM17 (0.68) ADAM17RAF1BRAFMEN1KMT2A
SCHEMBL1503584 0.81 ADAM17 (0.65) ADAM17RAF1BRAFMRGPRX4
SCHEMBL1503561 0.81 ADAM17 (0.58) ADAM17ALDH1A1MAPK14MEN1KMT2A
SCHEMBL1503484 0.81 ADAM17 (0.77) ADAM17
SCHEMBL1503486 0.81 ADAM17 (0.77) ADAM17
SCHEMBL1503664 0.80 ADAM17 (0.52) ADAM17ALDH1A1RAF1BRAFPOLB
SCHEMBL12077180 0.74 ADAM17 (0.60) ADAM17ALDH1A1CYP4F2CYP4A11HDAC1
SCHEMBL1503540 0.71 ALDH1A1 (0.53) ALDH1A1MEN1KMT2A
SCHEMBL1503650 0.71 ALDH1A1 (0.59) ALDH1A1POLBKMT2ANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033010-A1 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-03-24 WO disclosed